If you believe what
medical technology executives are saying at the annual Advanced Medical
Technology Association conference in Minneapolis, the
device industry wants to change the agency driving reimbursement
decisions: the Centers for Medicare & Medicaid Services.
The Food and Drug Administration, which ensures a device’s safety and efficacy before it’s allowed on the U.S. market, traditionally served as the device industry’s boogeyman. Industry executives have long called for shorter FDA review times for products and more transparent and predictable decisions from the agency.
With the industry having some success in getting those changes at the FDA, it seems the CMS is now seen as the major hurdle impeding growth at medical technology companies. At issue is the time lag between a product's approval for the U.S. market and a decision on whether Medicare will cover it. Many in the device industry believe the time between the FDA decision on a new device's safety and efficacy and when the CMS makes a coverage determination for the product is too long. Acquiring CMS coverage for a new medical device is crucial to a product's success, especially as many private payers partially base their own coverage determinations on what the Medicare agency decides.
The Medicare agency needs to improve its policies for
covering new medical technologies, the president and CEO of device maker CVRx said at the AdvaMed
conference Oct. 17. AdvaMed also views this as a problem and plans
to push Congress and the
to make it easier for manufacturers to get new devices covered, CVRx's Nadim
Yared said. Yared is also on AdvaMed's board.
The industry’s call for change at the CMS comes as the
agency is trying to squeeze more value out of devices. However, medical
technology companies must demonstrate the value of their devices on aspects
other than price as bundled payment models become more common, a Magellan
Health executive said
at the conference Oct. 18. For example, device manufacturers need to prove
their products shorten hospital stays and reduce complications, David Hodges
said at the conference
. Hodges is the chief medical officer of Magellan
Health, a for-profit managed care company based in Columbia, Md.
Bundled payment models are one way the
trying to reduce variations in treatment costs among hospitals while improving
outcomes. With bundled payments, hospitals receive one payment for an entire
episode of care that spans acute and post-acute care instead of receiving
separate pay for individual services under the fee-for-service schedule.
Hospitals could face a financial downside for not coordinating follow-up care
and some are looking to derive more value from the devices they use, which may
prompt medical technology companies to change how they design and sell their
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)